Kidney Health for Everyone Everywhere-From Prevention to Detection and Equitable Access to Care (scientific article published on 01 January 2020)

Epidemiology, molecular, and genetic methodologies to evaluate causes of CKDu around the world: report of the Working Group from the ISN International Consortium of Collaborators on CKDu

Q91412155

Analysis from the EMPA-REG OUTCOME® trial indicates empagliflozin may assist in preventing the progression of chronic kidney disease in patients with type 2 diabetes irrespective of medications that alter intrarenal hemodynamics

Q92379855

Does AKI truly lead to CKD?

Q27024744

Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease

Q29037884

Reducing the costs of chronic kidney disease while delivering quality health care: a call to action

Q30234324

Multidisciplinary care for poor patients with chronic kidney disease in Mexico

Q33873427

A report with consensus statements of the International Society of Nephrology 2004 Consensus Workshop on Prevention of Progression of Renal Disease, Hong Kong, June 29, 2004.

Q36064004

Primary health care strategies for the prevention of end-stage renal disease in Cuba

Q36192860

Educating Patients about CKD: The Path to Self-Management and Patient-Centered Care

Q36770881

Testing for chronic kidney disease: a position statement from the National Kidney Foundation

Q36894958

Prevalence, awareness, and management of CKD and cardiovascular risk factors in publicly funded health care

Q37682234

Epidemiology, impact and preventive care of chronic kidney disease in Taiwan

Q37768524

Screening for, monitoring, and treatment of chronic kidney disease stages 1 to 3: a systematic review for the U.S. Preventive Services Task Force and for an American College of Physicians Clinical Practice Guideline

Q38003117

Web-based kidney education: supporting patient self-management

Q38086357

Chronic kidney disease and cardiovascular risk in six regions of the world (ISN-KDDC): a cross-sectional study

Q38993676

Public lacks knowledge on chronic kidney disease: telephone survey

Q39232274

Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study

Q39599282

Consent for research with biological samples: one-time general consent versus a gift model

Q39628467

Chronic kidney disease in low-income to middle-income countries: the case for increased screening

Q42764188

Comprehensive public health strategies for preventing the development, progression, and complications of CKD: report of an expert panel convened by the Centers for Disease Control and Prevention

Q43415177

Nutritional Management of Chronic Kidney Disease

Q46337855

Relatives in silent kidney disease screening (RISKS) study: A Chinese cohort study.

Q47384990

Chronic Kidney Disease.

Q51043966

Chronic kidney disease care models in low- and middle-income countries: a systematic review.

Q52599507

The global burden of kidney disease and the sustainable development goals.

Q55223494

Asian Chronic Kidney Disease (CKD) Best Practice Recommendations - Positional Statements for Early Detection of CKD from Asian Forum for CKD Initiatives (AFCKDI)

Q57371443

Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016–40 for 195 countries and territories

Q57421040

Obesity and Kidney Disease: Hidden Consequences of the Epidemic

Q57771319

Morbidity and mortality of renal dialysis: an NIH consensus conference statement. Consensus Development Conference Panel

Q72487112

Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes

Q80477531

Early identification and management of chronic kidney disease: summary of NICE guidance

Q82112946

P433

issue

P304

page(s)

5-11

P577

publication date

2020-01-01

P1433